Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial [Phase 3]

View source ↗

Summary

A Phase 3 trial called STROKE75+ is evaluating a new strategy to prevent recurrent ischemic strokes in older adults; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Stroke, Ischemic | Phase 3 | Status: NOT_YET_RECRUITING